Francois Cedric 4
4 · Apellis Pharmaceuticals, Inc. · Filed Jan 30, 2026
Research Summary
AI-generated summary of this filing
Apellis (APLS) CEO Francois Cedric Receives 195,952 RSU Award
What Happened
- Francois Cedric, CEO of Apellis Pharmaceuticals (APLS), was granted 195,952 restricted stock units (RSUs) on January 28, 2026. The Form 4 reports the acquisition as 195,952 shares at $0.00 (typical for RSU grants), total reported value $0 on the form.
Key Details
- Transaction date: 2026-01-28; filing date: 2026-01-30.
- Transaction type/code: Award/Grant (A) — Restricted Stock Units (RSUs).
- Grant size: 195,952 RSUs; price per share on form: $0.00.
- Vesting: 25% annually over four years from the grant date, subject to continued service (footnote F1).
- Shares owned after transaction: not specified in the filing.
- Trust/ownership notes: certain Apellis shares are held in several trusts (The Cedric Francois Irrevocable Trusts of 2023 and others). The reporting person disclaims beneficial ownership of those trust-held shares except to the extent of any pecuniary interest (footnotes F2–F5).
- No indication in the filing that this was a sale or exercise; it is a compensation award.
Context
- RSU grants are compensation and typically vest over time; they do not represent an immediate cash purchase or sale. Such awards are common for executive pay and do not by themselves indicate the executive’s near-term buying or selling intentions.
Insider Transaction Report
Form 4
Francois Cedric
DirectorChief Executive Officer
Transactions
- Award
Common Stock
[F1]2026-01-28+195,952→ 481,997 total
Holdings
- 307,946(indirect: By Trust)
Common Stock
[F2] - 472,065(indirect: By Trust)
Common Stock
[F3] - 300,000(indirect: By Trust)
Common Stock
[F4] - 234,411(indirect: By Trust)
Common Stock
[F5]
Footnotes (5)
- [F1]This represents a Restricted Stock Unit award granted on January 28, 2026 that vest 25% annually over four years from grant date subject to continued service.
- [F2]The securities are held by The Cedric Francois Irrevocable Trust of 2023 - 2. William V. A. Zorn is the trustee of The Cedric Francois Irrevocable Trust of 2023 - 2. The reporting person disclaims beneficial ownership over the shares held by The Cedric Francois Irrevocable Trust of 2023 - 2 except to the extent of his pecuniary interest therein.
- [F3]The securities are held by The Cedric Francois Irrevocable Trust of 2023. William V. A. Zorn is the trustee of The Cedric Francois Irrevocable Trust of 2023. The reporting person disclaims beneficial ownership over the shares held by The Cedric Francois Irrevocable Trust of 2023 except to the extent of his pecuniary interest therein.
- [F4]The securities are held by The Francois Grossi Trust, for which Juliana Grossi, the spouse of the reporting person, serves as trustee. The reporting person disclaims beneficial ownership over the shares held by the Francois Grossi Trust except to the extent of his pecuniary interest therein.
- [F5]The securities are held by The Francois-DuBois Educational Trust, for which the Fiduciary Trust Company of New England serves as trustee. The reporting person disclaims beneficial ownership over the shares held by The Francois-DuBois Educational Trust except to the extent of his pecuniary interest therein.
Signature
/s/ David Watson, attorney-in-fact for Cedric Francois|2026-01-29